Expression profiling of differentiating eosinophils in bone marrow cultures predicts functional links between microRNAs and their target mRNAs

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Yang, Ming ^a   Eyers, Fiona ^a   Xiang, Yang ^b   Guo, Man ^b   Young, Ian G ^c   Rosenberg, Helene F ^d   Foster, Paul S ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b Central South University   (China)

^c Australian National University   (Australia)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR3; INTERLEUKIN 5 RECEPTOR ALPHA; MICRORNA; TOLL LIKE RECEPTOR; UNTRANSLATED RNA; GIEMSA STAIN; MESSENGER RNA; PRIMER DNA;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; EOSINOPHIL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MICROARRAY ANALYSIS; MICROENVIRONMENT; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; BAGG ALBINO MOUSE; FLOW CYTOMETRY; GENETICS; GERMFREE ANIMAL; GIEMSA STAIN; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; AZURE STAINS; BONE MARROW CELLS; CELL DIFFERENTIATION; DNA PRIMERS; EOSINOPHILS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICE; MICE, INBRED BALB C; MICROARRAY ANALYSIS; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84901259374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097537     Document Type: Article

References (81)

1. Melo RC, Liu L, Xenakis JJ, Spencer LA (2013) Eosinophil-derived cytokines in health and disease: unraveling novel mechanisms of selective secretion. Allergy 68: 274-284.
2. Rosenberg HF, Dyer KD, Foster PS (2013) Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 13: 9-22.
3. Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, et al. (2012) Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 130: 607-612 e609.
4. Rothenberg ME, Hogan SP (2006) The eosinophil. Annu Rev Immunol 24: 147-174.
5. Foster PS, Mould AW, Yang M, Mackenzie J, Mattes J, et al. (2001) Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev 179: 173-181. (Pubitemid 32171284)
6. Rosenberg HF, Phipps S, Foster PS (2007) Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 119: 1303-1310; quiz 1311-1302.
7. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ (1995) Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 182: 1169-1174.
8. Mould AW, Matthaei KI, Young IG, Foster PS (1997) Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 99: 1064-1071. (Pubitemid 27123644)
9. Sanderson CJ (1992) Interleukin-5, eosinophils, and disease. Blood 79: 3101-3109.
10. Ponath PD, Qin S, Post TW, Wang J, Wu L, et al. (1996) Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 183: 2437-2448. (Pubitemid 26192353)
11. Zimmermann N, Hogan SP, Mishra A, Brandt EB, Bodette TR, et al. (2000) Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 165: 5839-5846.
12. Shinkai A, Yoshisue H, Koike M, Shoji E, Nakagawa S, et al. (1999) A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 163: 1602-1610. (Pubitemid 29352785)
13. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG (1996) Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183: 195-201. (Pubitemid 26028759)
14. Yoshida T, Ikuta K, Sugaya H, Maki K, Takagi M, et al. (1996) Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity 4: 483-494. (Pubitemid 26354657)
15. Ma W, Bryce PJ, Humbles AA, Laouini D, Yalcindag A, et al. (2002) CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 109: 621-628. (Pubitemid 34204841)
16. Humbles AA, Lu B, Friend DS, Okinaga S, Lora J, et al. (2002) The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci U S A 99: 1479-1484. (Pubitemid 34136518)
17. Menzies-Gow A, Flood-Page P, Sehmi R, Burman J, Hamid Q, et al. (2003) Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 111: 714-719. (Pubitemid 36470238)
18. Molfino NA, Gossage D, Kolbeck R, Parker JM, Geba GP (2012) Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor. Clin Exp Allergy 42: 712-737.
19. Castro M, Mathur S, Hargreave F, Boulet LP, Xie F, et al. (2011) Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 184: 1125-1132.
20. Hirasawa R, Shimizu R, Takahashi S, Osawa M, Takayanagi S, et al. (2002) Essential and instructive roles of GATA factors in eosinophil development. J Exp Med 195: 1379-1386. (Pubitemid 34602815)
21. Dyer KD, Moser JM, Czapiga M, Siegel SJ, Percopo CM, et al. (2008) Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J Immunol 181: 4004-4009.
22. Dyer KD, Czapiga M, Foster B, Foster PS, Kang EM, et al. (2007) Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo. J Immunol 179: 1693-1699.
23. Yu C, Cantor AB, Yang H, Browne C, Wells RA, et al. (2002) Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med 195: 1387-1395. (Pubitemid 34602816)
24. Bedi R, Du J, Sharma AK, Gomes I, Ackerman SJ (2009) Human C/EBP-epsilon activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation. Blood 113: 317-327.
25. Du J, Stankiewicz MJ, Liu Y, Xi Q, Schmitz JE, et al. (2002) Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein. J Biol Chem 277: 43481-43494. (Pubitemid 35285737)
26. Iwasaki H, Mizuno S, Arinobu Y, Ozawa H, Mori Y, et al. (2006) The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev 20: 3010-3021. (Pubitemid 44771735)
27. Yamanaka R, Barlow C, Lekstrom-Himes J, Castilla LH, Liu PP, et al. (1997) Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci U S A 94: 13187-13192. (Pubitemid 27518497)
28. Bettigole SE, Spencer LA, Weller PF, Glimercher LH (July 15, 2013. Oxford, UK) The transcription factor XBP-1 is a critical regulator of eosinophil development. Paper presented at 8th Biennial Symposium of the International Eosinophil Society.
29. Taghon T, Yui MA, Rothenberg EV (2007) Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3. Nat Immunol 8: 845-855. (Pubitemid 47099037)
30. Abraham SN, St John AL (2010) Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 10: 440-452.
31. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
32. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9: 839-845. (Pubitemid 352038302)
33. Yang M, Mattes J (2008) Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacol Ther 117: 94-104. (Pubitemid 350199690)
34. Foster PS, Plank M, Collison A, Tay HL, Kaiko GE, et al. (2013) The emerging role of microRNAs in regulating immune and inflammatory responses in the lung. Immunol Rev 253: 198-215.
35. Mattes J, Collison A, Plank M, Phipps S, Foster PS (2009) Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci U S A 106: 18704-18709.
36. Wong CK, Lau KM, Chan IH, Hu S, Lam YY, et al. (2013) MicroRNA-21*regulates the prosurvival effect of GM-CSF on human eosinophils. Immunobiology 218: 255-262.
37. Lu TX, Lim EJ, Besse JA, Itskovich S, Plassard AJ, et al. (2013) MiR-223 deficiency increases eosinophil progenitor proliferation. J Immunol 190: 1576-1582.
38. Dyer KD, Garcia-Crespo KE, Killoran KE, Rosenberg HF (2011) Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry. J Immunol Methods 369: 91-97.
39. Rasmussen KD, Simmini S, Abreu-Goodger C, Bartonicek N, Di Giacomo M, et al. (2010) The miR-144/451 locus is required for erythroid homeostasis. J Exp Med 207: 1351-1358.
40. Rusca N, Deho L, Montagner S, Zielinski CE, Sica A, et al. (2012) MiR-146a and NF-kappaB1 regulate mast cell survival and T lymphocyte differentiation. Mol Cell Biol 32: 4432-4444.
41. Hu YL, Fong S, Largman C, Shen WF (2010) HOXA9 regulates miR-155 in hematopoietic cells. Nucleic Acids Res 38: 5472-5478.
42. Sun L, Xie H, Mori MA, Alexander R, Yuan B, et al. (2011) Mir193b-365 is essential for brown fat differentiation. Nat Cell Biol 13: 958-965.
43. Hino K, Tsuchiya K, Fukao T, Kiga K, Okamoto R, et al. (2008) Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation. RNA 14: 1433-1442. (Pubitemid 351872199)
44. Wang X, Zhang X, Ren XP, Chen J, Liu H, et al. (2010) MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 122: 1308-1318.
45. Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, et al. (2013) MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood.
46. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, et al. (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451: 1125-1129. (Pubitemid 351317447)
47. Nerlov C, Graf T (1998) PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev 12: 2403-2412. (Pubitemid 28371359)
48. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
49. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, et al. (2011) Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 18: 1139-1146.
50. Her E, Frazer J, Austen KF, Owen WF, Jr. (1991) Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest 88: 1982-1987.
51. Kampe M, Lampinen M, Stolt I, Janson C, Stalenheim G, et al. (2012) PI3-kinase regulates eosinophil and neutrophil degranulation in patients with allergic rhinitis and allergic asthma irrespective of allergen challenge model. Inflammation 35: 230-239.
52. Bouchon A, Facchetti F, Weigand MA, Colonna M (2001) TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410: 1103-1107. (Pubitemid 32391042)
53. Hallgren R, Feltelius N, Svenson K, Venge P (1985) Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein. Clin Exp Immunol 59: 539-546. (Pubitemid 15127602)
54. Mertens AV, De Clerck LS, Moens MM, Bridts CH, Stevens WJ (1993) Study of eosinophil-endothelial adhesion, production of oxygen radicals and release of eosinophil cationic protein by peripheral blood eosinophils of patients with rheumatoid arthritis. Clin Exp Allergy 23: 868-873. (Pubitemid 23327383)
55. Plotz SG, Lentschat A, Behrendt H, Plotz W, Hamann L, et al. (2001) The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent. Blood 97: 235-241. (Pubitemid 32061266)
56. Nagase H, Okugawa S, Ota Y, Yamaguchi M, Tomizawa H, et al. (2003) Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J Immunol 171: 3977-3982. (Pubitemid 37238671)
57. Phipps S, Lam CE, Mahalingam S, Newhouse M, Ramirez R, et al. (2007) Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood 110: 1578-1586. (Pubitemid 47443974)
58. Persson CG, Erjefalt JS, Korsgren M, Sundler F (1997) The mouse trap. Trends Pharmacol Sci 18: 465-467. (Pubitemid 28051763)
59. Wenzel SE (2009) Eosinophils in asthma-closing the loop or opening the door? N Engl J Med 360: 1026-1028.
60. Lee JJ, Jacobsen EA, Ochkur SI, McGarry MP, Condjella RM, et al. (2012) Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red". J Allergy Clin Immunol 130: 572-584.
61. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601. (Pubitemid 351627379)
62. Lu TX, Lim EJ, Itskovich S, Besse JA, Plassard AJ, et al. (2013) Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth. PLoS One 8: e59397.
63. Parsons MJ, Grimm CH, Paya-Cano JL, Sugden K, Nietfeld W, et al. (2008) Using hippocampal microRNA expression differences between mouse inbred strains to characterise miRNA function. Mamm Genome 19: 552-560.
64. de Haan G, Nijhof W, Van Zant G (1997) Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood 89: 1543-1550. (Pubitemid 27097446)
65. Muller-Sieburg CE, Riblet R (1996) Genetic control of the frequency of hematopoietic stem cells in mice: mapping of a candidate locus to chromosome 1. J Exp Med 183: 1141-1150. (Pubitemid 26113977)
66. Gerrits A, Walasek MA, Olthof S, Weersing E, Ritsema M, et al. (2012) Genetic screen identifies microRNA cluster 99b/let-7e/125a as a regulator of primitive hematopoietic cells. Blood 119: 377-387.
67. Jin Y, Tymen SD, Chen D, Fang ZJ, Zhao Y, et al. (2013) MicroRNA-99 family targets AKT/mTOR signaling pathway in dermal wound healing. PLoS One 8: e64434.
68. Furumoto Y, Charles N, Olivera A, Leung WH, Dillahunt S, et al. (2011) PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability. Blood 118: 5466-5475.
69. von Kockritz-Blickwede M, Nizet V (2009) Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps. J Mol Med (Berl) 87: 775-783.
70. Oldenburg M, Kruger A, Ferstl R, Kaufmann A, Nees G, et al. (2012) TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 337: 1111-1115.
71. Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, et al. (2005) The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci U S A 102: 9577-9582. (Pubitemid 40981723)
72. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
73. Wang Y, Liu J, Liu C, Naji A, Stoffers DA (2013) MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic beta-cells. Diabetes 62: 887-895.
74. Chen Y, Gorski DH (2008) Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111: 1217-1226. (Pubitemid 351213403)
75. Li T, Cao H, Zhuang J, Wan J, Guan M, et al. (2011) Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta 412: 66-70.
76. Bhanja Chowdhury J, Shrivastava S, Steele R, Di Bisceglie AM, Ray R, et al. (2012) Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. J Virol 86: 10221-10225.
77. Yang L, Li N, Wang H, Jia X, Wang X, et al. (2012) Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. Oncol Rep 28: 592-600.
78. Kim YJ, Bae SW, Yu SS, Bae YC, Jung JS (2009) miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res 24: 816-825.
79. Kashiyama K, Mitsutake N, Matsuse M, Ogi T, Saenko VA, et al. (2012) miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts. J Invest Dermatol 132: 1597-1604.
80. Pin AL, Houle F, Fournier P, Guillonneau M, Paquet ER, et al. (2012) Annexin-1-mediated endothelial cell migration and angiogenesis are regulated by vascular endothelial growth factor (VEGF)-induced inhibition of miR-196a expression. J Biol Chem 287: 30541-30551.
81. Sun M, Liu XH, Li JH, Yang JS, Zhang EB, et al. (2012) MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1). Mol Cancer Ther 11: 842-852.